A Study Evaluating TJ210001 in the Treatment of Subjects With Advanced Solid Tumors

NCT04947033 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

25

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumor

Interventions

DRUG: TJ210001 Injection

Sponsor

I-Mab Biopharma US Limited